Adlai Nortye Ltd. (ANL) Financials

ANL Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 248.4 million 33.5 million
March 31, 2026 248.4 million 33.5 million
Dec. 31, 2025 34.4 million 42.8 million
Sept. 30, 2025 34.4 million 42.8 million

ANL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -7.7 million ?
March 31, 2026 -7.7 million 1.5 million
Dec. 31, 2025 -33.6 million 1.5 million
Sept. 30, 2025 -9.3 million 766000

ANL Net Income

No data available :(

ANL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 232.8 million - -
March 31, 2026 232.8 million - -
Dec. 31, 2025 - - 1.8 million
Sept. 30, 2025 9.0 million - -

ANL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 15.9 million
March 31, 2026 15.9 million
Dec. 31, 2025 176.2 million
Sept. 30, 2025 10.7 million

ANL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 7.3 million 2.9 million -
March 31, 2026 187000 7.3 million 2.9 million -
Dec. 31, 2025 187000 8.8 million 2.1 million -
Sept. 30, 2025 93500 8.8 million 2.1 million -

ANL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 7.3 million -
March 31, 2026 7.3 million -
Dec. 31, 2025 2.5 million -
Sept. 30, 2025 2.5 million -

ANL

Price: $13.72

52 week price:
0.88
17.25

Earnings Per Share: -0.66 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 922.8 million

Links: